Insights

Strategic platform GenomSys offers an open standard platform based on ISO/IEC 23092 MPEG-G for scalable and interoperable genomic applications, presenting a strong upsell opportunity to partners seeking compliant, future-ready data workflows and faster time-to-market.

Cost and speed The solution highlights storage reductions of around 70 percent and a four-month faster development cycle for new applications, making it attractive to organizations under cost pressure or needing rapid deployment of genomics tools.

Medical device readiness As an ISO-13485 certified software manufacturer for medical devices, GenomSys can address quality and regulatory requirements for medical-grade genomic software, appealing to healthcare providers and pharma partners seeking compliant solutions.

Key partnerships Historical collaborations with Philips and notable product launches (Variant Analyzer CE marking, GenomYou app) indicate a proven channel strategy and potential co-development or licensing opportunities with large health technology players.

Strategic growth signals Despite a small headcount, GenomSys has secured $9.4M in funding and pursuing high-value, regulatory-conscious genomic software, signaling readiness for targeted enterprise engagement and scalable customer onboarding in personalized genomics.

Similar companies to GenomSys

GenomSys Tech Stack

GenomSys uses 8 technology products and services including Amazon Web Services, Docker, WordPress, and more. Explore GenomSys's tech stack below.

Media & News

GenomSys's Email Address Formats

GenomSys uses at least 1 email format:
GenomSys Email FormatsExamplePercentage
First.Last@genomsys.comJohn.Doe@genomsys.com
100%

Frequently Asked Questions

What is GenomSys's official website and social media links?

Minus sign iconPlus sign icon
GenomSys's official website is genomsys.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does GenomSys generate?

Minus sign iconPlus sign icon
As of July 2026, GenomSys's annual revenue is estimated to be <$1M.

What is GenomSys's SIC code and NAICS code?

Minus sign iconPlus sign icon
GenomSys's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does GenomSys have currently?

Minus sign iconPlus sign icon
As of July 2026, GenomSys has approximately 6 employees across 2 continents, including Europe and North America. Key team members include Ceo: A. A., Head Of Software Development: A. L. C. and Co-Founder: C. A. Explore GenomSys's employee directory with LeadIQ.

What industry does GenomSys belong to?

Minus sign iconPlus sign icon
GenomSys operates in the Biotechnology Research industry.

What technology does GenomSys use?

Minus sign iconPlus sign icon
GenomSys's tech stack includes Amazon Web Services, Docker, WordPress, CookieYes, Shopify, Mailchimp, Microsoft 365 and Microsoft Azure.

What is GenomSys's email format?

Minus sign iconPlus sign icon
GenomSys's email format typically follows the pattern of First.Last@genomsys.com. Find more GenomSys email formats with LeadIQ.

How much funding has GenomSys raised to date?

Minus sign iconPlus sign icon
As of July 2026, GenomSys has raised $9.4M in funding. The last funding round occurred on Sep 16, 2019 for $9.4M.

When was GenomSys founded?

Minus sign iconPlus sign icon
GenomSys was founded in 2016.
GenomSys logo

GenomSys

Biotechnology ResearchVaud, Switzerland2-10 Employees

GenomSys is a Swiss health software company focused on advancing personalized genomics through an open standard platform designed to support scalable and secure genomic 2.0 applications. Its offerings aim to improve data and process efficiency, interoperability, and software robustness as genomic data volumes grow, delivering cost savings and faster time-to-market for new applications. The company markets a multi-infrastructure platform aligned with the ISO/IEC 23092 MPEG-G standard, aiming to facilitate rapid development and regulatory-ready solutions in genomics, including mobile-friendly workflows. Based in Vaud, Switzerland, GenomSys operates in the biotechnology research sector and has pursued CE marking for its software, signaling clinical compatibility. A recent development includes ongoing collaborations and product releases tied to its CE-marked GenomSys Variant Analyzer, illustrating continued advancement of its genomic analysis tools.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
2-10

Section iconFunding & Financials

  • $9.4M

    GenomSys has raised a total of $9.4M of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2019 in the amount of $9.4M as a Series A.

  • <$1M

    GenomSys's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.